Published in Drugs on August 01, 2000
Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95
Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Respir Res (2006) 0.80
Biological targets for therapeutic interventions in COPD: clinical potential. Int J Chron Obstruct Pulmon Dis (2006) 0.75
Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials. BMC Pulm Med (2004) 0.75
Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis (1991) 2.95
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J (2002) 2.84
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation (1999) 2.55
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J (2004) 2.06
Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J (2002) 2.04
Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1994) 1.63
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy (2004) 1.58
Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J (1998) 1.50
Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir Med (2007) 1.46
Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J (1999) 1.22
Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. Am J Respir Crit Care Med (2000) 1.10
GP management of community-acquired pneumonia in Italy: the ISOCAP study. Monaldi Arch Chest Dis (2005) 1.07
Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med (2007) 1.05
The influence of personal tobacco smoking on the clinical practice of Italian chest physicians. Eur Respir J (1998) 1.04
Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group. Eur Respir J (1999) 1.01
Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis (1993) 1.01
Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy (2001) 1.01
Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med (1996) 0.98
Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest (1993) 0.98
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis. Eur Respir J (2005) 0.97
Effects of high-altitude periodic breathing on sleep and arterial oxyhaemoglobin saturation. Eur Respir J (1998) 0.97
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest (1992) 0.95
On pulmonary rehabilitation and the flight of the bumblebee: the ATS/ERS Statement on Pulmonary Rehabilitation. Eur Respir J (2006) 0.94
GOLD severity stratification and risk of hospitalisation for COPD exacerbations. Monaldi Arch Chest Dis (2008) 0.92
Caregiver strain associated with tracheostomy in chronic respiratory failure. Chest (2001) 0.92
Comparison of invasive and noninvasive saturation monitoring in prescribing oxygen during exercise in COPD patients. Eur Respir J (1997) 0.91
Static intrinsic PEEP in COPD patients during spontaneous breathing. Am J Respir Crit Care Med (1998) 0.88
Semi-quantitative X-ray microanalysis of bronchoalveolar lavage samples from silica-exposed and nonexposed subjects. Eur Respir J (1992) 0.86
Diaphragm fatigue during exercise at high altitude: the role of hypoxia and workload. Eur Respir J (2001) 0.86
Cardiovascular and ventilatory response to isocapnic hypoxia at sea level and at 5,050 m. J Appl Physiol (1985) (1996) 0.86
Clinical guidelines and indications for bronchoalveolar lavage (BAL): occupational lung diseases due to inhalation of inorganic dust. Eur Respir J (1990) 0.85
Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation? Chest (2000) 0.83
Personal smoking habit and attitude toward smoking among the health staff of a general hospital. Monaldi Arch Chest Dis (1998) 0.83
Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration (1992) 0.83
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir Med (2007) 0.82
Comparison of gas exchange, lactate, and lactic acidosis thresholds in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.82
Proliferation and inflammation in bronchial epithelium after allergen in atopic asthmatics. Clin Exp Allergy (2003) 0.82
Airways inflammation in subjects with chronic bronchitis who have never smoked. Thorax (1994) 0.82
In vitro effect of beta 2-agonists on bacterial killing and superoxide anion (O2-) release from alveolar macrophages of patients with chronic bronchitis. Chest (1993) 0.81
Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders. Am J Respir Crit Care Med (1997) 0.81
Relationship between the perception of breathlessness and inspiratory resistive loading: report on a clinical trial. Eur Respir J Suppl (1989) 0.81
Preventive treatment of chronic bronchitis: a meta-analysis of clinical trials with a bacterial extract (OM-85 BV) and a cost-effectiveness analysis. Monaldi Arch Chest Dis (1994) 0.81
Physiologic response of ventilator-dependent patients with chronic obstructive pulmonary disease to proportional assist ventilation and continuous positive airway pressure. Am J Respir Crit Care Med (1999) 0.81
The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients. Respir Med (2002) 0.80
Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease. Thorax (1999) 0.80
Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study). Monaldi Arch Chest Dis (2009) 0.80
Nocturnal asthma: mechanisms and therapy. Lung (1997) 0.80
A new questionnaire specifically designed for patients affected by chronic obstructive pulmonary disease; The Italian Health Status Questionnaire. Respir Med (2005) 0.80
Sustained-release anhydrous theophylline in preventing exercise-induced asthma. Respiration (1984) 0.79
EDU-CARE, a randomised, multicentre, parallel group study on education and quality of life in COPD. Monaldi Arch Chest Dis (2002) 0.79
Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections. Pulm Pharmacol Ther (2001) 0.79
Methods for evaluation of protein components in bronchoalveolar lavage fluids. Clin Chem (1993) 0.78
Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases. Monaldi Arch Chest Dis (2003) 0.78
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease. Eur J Clin Pharmacol (1999) 0.78
Proposal of an easy method to improve routine sputum bacteriology. Respiration (1989) 0.78
A new perspective in pulmonary rehabilitation: anaerobic threshold as a discriminant in training. Eur Respir J Suppl (1989) 0.78
Patient selection and techniques for home mechanical ventilation. Eur Respir J (1993) 0.78
Interaction between drugs and lung immune defences in COPD: local evaluation with bronchoalveolar lavage. Monaldi Arch Chest Dis (1993) 0.77
Selection criteria for exercise training in patients with COPD. Z Kardiol (1994) 0.77
Ventilatory and metabolic changes as a result of exercise training in COPD patients. Chest (1992) 0.77
The effects of doxofylline versus theophylline on sleep architecture in COPD patients. Monaldi Arch Chest Dis (1995) 0.77
Pulmonary failure as a cause of death in COPD. Monaldi Arch Chest Dis (1997) 0.77
Inflammatory and immune reactions associated with inorganic dust exposure: comparison between patients with and without clinical lung involvement. Eur Respir J (1990) 0.77
Severe vs. mild COPD: a different disease? Monaldi Arch Chest Dis (2004) 0.76
The clinical and integrated management of COPD. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.76
Acid phosphatase (EC 3.1.3.2) activity in alveolar macrophages from patients with active sarcoidosis. Chest (1991) 0.76
Protective effect and duration of action of formoterol aerosol on exercise-induced asthma. Eur Respir J (1991) 0.75
Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J (2002) 0.75
Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease. Thorax (1999) 0.75
Long-term nocturnal mechanical ventilation in patients with kyphoscoliosis. Monaldi Arch Chest Dis (1995) 0.75
Timing of tracheostomy in neuromuscular patients with chronic respiratory failure. Monaldi Arch Chest Dis (1995) 0.75
Quality of life and chronic respiratory failure. Monaldi Arch Chest Dis (1997) 0.75
Guidelines for COPD management. Monaldi Arch Chest Dis (2003) 0.75
Intermediate respiratory care unit: admission criteria. Monaldi Arch Chest Dis (1994) 0.75
Selection and evaluation of recipients for heart-lung and lung transplantation: the Niguarda Hospital experience. Monaldi Arch Chest Dis (1994) 0.75
LTOT in pulmonary fibrosis. Monaldi Arch Chest Dis (1993) 0.75
Asthma controller therapy: role of antileukotrienes, a new therapeutic class. Monaldi Arch Chest Dis (1999) 0.75
Influence of clinical history on airways bacterial colonization in subjects with chronic tracheostomy. Respir Med (2000) 0.75
Blood pressure and heart rate during periodic breathing while asleep at high altitude. J Appl Physiol (1985) (2000) 0.75
Autocontinuous positive airway pressure in the diagnosis and treatment of obstructive sleep apnoea. Monaldi Arch Chest Dis (1998) 0.75
Respiratory mechanics and respiratory muscle performance in CO2 retainers during non-invasive mechanical ventilation. Monaldi Arch Chest Dis (1993) 0.75
Lower respiratory tract infections in chronic obstructive pulmonary disease outpatients with tracheostomy and persistent colonization by P. aeruginosa. Respir Med (2003) 0.75
Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol. Monaldi Arch Chest Dis (1995) 0.75
An investigation of the etiology of community-acquired lower respiratory tract infections (LRTI) and resistance to antibiotics in Italy (the EOLO Study). Monaldi Arch Chest Dis (2002) 0.75
Identification of human pulmonary alkaline phosphatase isoenzymes. Am J Respir Crit Care Med (1997) 0.75
The fundamentals of cardiopulmonary exercise testing. Monaldi Arch Chest Dis (1993) 0.75
[Sleep disordered breathing: a new risk factor for accidents]. G Ital Med Lav Ergon (2000) 0.75
Therapeutic strategies in weaning failure. Monaldi Arch Chest Dis (1998) 0.75
Reliability of a questionnaire for evaluating the understanding of asthma. Monaldi Arch Chest Dis (2001) 0.75
An update of GEPOR project activity. Monaldi Arch Chest Dis (1996) 0.75
Health Status measurement: an increasingly important outcome evaluation in COPD patients. Monaldi Arch Chest Dis (2001) 0.75
Long-term oxygen therapy. Monaldi Arch Chest Dis (1994) 0.75
Advances in pulmonary rehabilitation and management of chronic respiratory failure. Introduction to the proceedings. Monaldi Arch Chest Dis (2004) 0.75
Advances in pulmonary rehabilitation and management of chronic respiratory failure. Monaldi Arch Chest Dis (1998) 0.75
Home mechanical ventilation in kyphoscoliosis. Monaldi Arch Chest Dis (1993) 0.75
Tuberculosis in the world: the pattern of the new epidemic. Monaldi Arch Chest Dis (1994) 0.75
Quality of Life Evaluation and Survival Study: a 3-yr prospective multinational study on patients with chronic respiratory failure. Monaldi Arch Chest Dis (2001) 0.75
Respiratory medicine and Europe. Monaldi Arch Chest Dis (1996) 0.75